Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
lunes, octubre 26
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
MDxHealth SA
MDXH
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$0.1833
-0.0007
-0.38%
Últ. Act.: Oct 23, 7:59 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
MDxHealth Financials
MDxHealth (MDXH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Dow Surges 250 Points; M&T Bank Posts Upbeat Q3 Earnings
U.S. stocks mixed: Dow +0.48%, Nasdaq -0.65%, S&P -0.05%. Energy rose, tech fell, and M&T Bank beat Q3 estimates; oil eased, gold gained.
Avi Kapoor
PRO
MDxHealth Suspends FY2026 Revenue Guidance Of $110M-$115M; Reports Preliminary Q3 Revenue Of About $22.7M vs. $22.7M Year Ago
Benzinga Newsdesk
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA'
MDxHealth reports Q2 sales growth, mixed earnings and reaffirmed 2026 revenue guidance as tissue test volumes rise.
Vandana Singh
PRO
MDxHealth Affirms FY2026 Sales Guidance of $110.000M-$115.000M vs $98.814M Est
MDxHealth (NASDAQ:MDXH) affirms FY2026 sales outlook from $110.000 million-$115.000 million to $110.000 million-$115.000 million vs $98.814 million estimate.
Benzinga Newsdesk
PRO
MDxHealth Q2 EPS $(0.18) Misses $(0.16) Estimate, Sales $27.200M Beat $25.884M Estimate
MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. This is a 20 percent decrease over losses of $(0.15) per share from the same
Benzinga Newsdesk
PRO
MDxHealth Lowers FY2026 Sales Guidance from $137.000M-$140.000M to $110.000M-$115.000M vs $135.912M Est
MDxHealth (NASDAQ:MDXH) lowers FY2026 sales outlook from $137.000 million-$140.000 million to $110.000 million-$115.000 million vs $135.912 million estimate.
Benzinga Newsdesk
